These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30576679)

  • 21. Role of Erythropoietin in Cerebral Glioma: An Innovative Target in Neuro-Oncology.
    Torregrossa F; Aguennouz M; La Torre D; Sfacteria A; Grasso G
    World Neurosurg; 2019 Nov; 131():346-355. PubMed ID: 31658577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emergence of the erythropoietin/erythropoietin receptor system as a novel cardiovascular therapeutic target.
    Satoh K; Fukumoto Y; Nakano M; Kagaya Y; Shimokawa H
    J Cardiovasc Pharmacol; 2011 Dec; 58(6):570-4. PubMed ID: 21934628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endogenous erythropoietin and erythropoietin receptors in colorectal cancer; can we answer the questions?
    Čubranić A; Dobrila-Dintinjana R; Redžović A; Dintinjana M; Petranović D; Golčić M
    Med Hypotheses; 2016 Nov; 96():16-19. PubMed ID: 27959268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erythropoietin and erythropoietin receptor expression in vestibular schwannoma: potential role in tumor progression.
    Diensthuber M; Ilner T; Rodt T; Samii M; Brandis A; Lenarz T; Stöver T
    Otol Neurotol; 2007 Jun; 28(4):559-65. PubMed ID: 17429338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of signalling in non-erythroid cells by pharmacological levels of erythropoietin.
    Dunlop EA; Percy MJ; Boland MP; Maxwell AP; Lappin TR
    Neurodegener Dis; 2006; 3(1-2):94-100. PubMed ID: 16909043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeted near-infrared imaging of the erythropoietin receptor in human lung cancer xenografts.
    Doleschel D; Mundigl O; Wessner A; Gremse F; Bachmann J; Rodriguez A; Klingmüller U; Jarsch M; Kiessling F; Lederle W
    J Nucl Med; 2012 Feb; 53(2):304-11. PubMed ID: 22228796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Erythropoietin, erythropoiesis and beyond.
    Chateauvieux S; Grigorakaki C; Morceau F; Dicato M; Diederich M
    Biochem Pharmacol; 2011 Nov; 82(10):1291-303. PubMed ID: 21782802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Erythropoietin, a hypoxia-regulated factor, elicits a pro-angiogenic program in human mesenchymal stem cells.
    Zwezdaryk KJ; Coffelt SB; Figueroa YG; Liu J; Phinney DG; LaMarca HL; Florez L; Morris CB; Hoyle GW; Scandurro AB
    Exp Hematol; 2007 Apr; 35(4):640-52. PubMed ID: 17379074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Erythropoietin is involved in angiogenesis in human primary melanoma.
    Ribatti D; Nico B; Perra MT; Longo V; Maxia C; Annese T; Piras F; Murtas D; Sirigu P
    Int J Exp Pathol; 2010 Dec; 91(6):495-9. PubMed ID: 20804540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of erythropoietin in regulating angiogenesis.
    Kertesz N; Wu J; Chen TH; Sucov HM; Wu H
    Dev Biol; 2004 Dec; 276(1):101-10. PubMed ID: 15531367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Off-tumor targets compromise antiangiogenic drug sensitivity by inducing kidney erythropoietin production.
    Nakamura M; Zhang Y; Yang Y; Sonmez C; Zheng W; Huang G; Seki T; Iwamoto H; Ding B; Yin L; Foukakis T; Hatschek T; Li X; Hosaka K; Li J; Yu G; Wang X; Liu Y; Cao Y
    Proc Natl Acad Sci U S A; 2017 Nov; 114(45):E9635-E9644. PubMed ID: 29078273
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Erythropoietin and tumor angiogenesis.
    Ribatti D
    Stem Cells Dev; 2010 Jan; 19(1):1-4. PubMed ID: 19886790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Erythropoietin: a hormone with multiple functions.
    Lombardero M; Kovacs K; Scheithauer BW
    Pathobiology; 2011; 78(1):41-53. PubMed ID: 21474975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The erythropoietin receptor and its expression in tumor cells and other tissues.
    Farrell F; Lee A
    Oncologist; 2004; 9 Suppl 5():18-30. PubMed ID: 15591419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. No erythropoietin-induced growth is observed in non-small cell lung cancer cells.
    Frille A; Leithner K; Olschewski A; Olschewski H; Wohlkönig C; Hrzenjak A
    Int J Oncol; 2018 Feb; 52(2):518-526. PubMed ID: 29345289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of erythropoietin and erythropoietin receptor in tongue squamous cell carcinoma.
    Li HG; Li JS; Chen WL; Wang L; Wu DH; Lin ZY
    Br J Oral Maxillofac Surg; 2009 Sep; 47(6):470-5. PubMed ID: 19559511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Erythropoietin-induced activation of the JAK2/STAT5, PI3K/Akt, and Ras/ERK pathways promotes malignant cell behavior in a modified breast cancer cell line.
    Shi Z; Hodges VM; Dunlop EA; Percy MJ; Maxwell AP; El-Tanani M; Lappin TR
    Mol Cancer Res; 2010 Apr; 8(4):615-26. PubMed ID: 20353997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation and inhibition of the erythropoietin receptor by a membrane-anchored erythropoietin.
    Negre O; Fusil F; Henri A; Villette JM; Leboulch P; Beuzard Y; Payen E
    Exp Hematol; 2008 Apr; 36(4):412-23. PubMed ID: 18295963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of erythropoietin and erythropoietin receptor in malignant laryngeal tumors.
    Vukelic J; Dobrila-Dintinjana R; Jonjic N; Dekanic A; Ilijic V
    Med Hypotheses; 2013 Dec; 81(6):1155-8. PubMed ID: 24134826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Erythropoietin, Stem Cell Factor, and Cancer Cell Migration.
    Vazquez-Mellado MJ; Monjaras-Embriz V; Rocha-Zavaleta L
    Vitam Horm; 2017; 105():273-296. PubMed ID: 28629522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.